Research graph
References from Spatial Characteristics of Newly Diagnosed Grade 3 Glioma Assessed by Magnetic Resonance Metabolic and Diffusion Tensor Imaging. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2010 · External reference
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis
10.1016/s0360-3016(99)00284-9 · 1999 · External reference
Prognostic stratification of patients with anaplastic gliomas according to genetic profile
10.1002/cncr.22211 · 2006 · External reference
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
10.3171/jns.2003.99.3.0467 · 2003 · External reference
The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification
10.1016/j.jmr.2004.12.007 · 2005 · External reference
Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas
10.1016/j.neuroimage.2004.06.022 · 2004 · External reference
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours
10.1016/j.crad.2006.09.012 · 2007 · External reference
Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions
10.1007/s00234-001-0760-0 · 2002 · External reference
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI
10.1016/j.ijrobp.2003.08.023 · 2004 · External reference
Multivoxel magnetic resonance spectroscopy of brain tumors
2003 · External reference
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
10.3171/jns.2002.97.4.0794 · 2002 · External reference
Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation
10.1016/j.clinimag.2007.12.006 · 2008 · External reference
Metabolic profiles of human brain tumors using quantitative in vivo1H magnetic resonance spectroscopy
10.1002/mrm.10367 · 2003 · External reference
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens
2001 · External reference
Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients
10.1002/jmri.10147 · 2002 · External reference
MRI for identification of progression in brain tumors: from morphology to function
10.1586/14737175.8.10.1507 · 2008 · External reference
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery
2001 · External reference
Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas
10.1002/nbm.858 · 2004 · External reference
MR-spectroscopy guided target delineation for high-grade gliomas
10.1016/s0360-3016(01)01548-6 · 2001 · External reference
Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors
10.1023/a:1006387703127 · 1999 · External reference
Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
10.1016/s0360-3016(02)02869-9 · 2002 · External reference
In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI
10.1002/jmri.10183 · 2002 · External reference
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for grade IV glioma
10.3171/jns.2004.101.3.0467 · 2004 · External reference
Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study
10.1002/jmri.1880070630 · 1997 · External reference
Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma
2006 · External reference
1H MR spectroscopy of brain tumours and masses
10.1002/nbm.822 · 2003 · External reference
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
10.3171/jns.1997.87.4.0525 · 1997 · External reference
Imaging of brain tumors after therapy
10.1016/s1052-5149(25)00603-3 · 1999 · External reference
Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI
10.1002/(sici)1099-1492(199905)12:3<123::aid-nbm541>3.0.co;2-y · 1999 · External reference
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas
10.1002/nbm.1059 · 2006 · External reference
Characterization of untreated gliomas by magnetic resonance spectroscopic imaging
10.1016/s1052-5149(02)00037-0 · 2002 · External reference
Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema
10.1002/jmri.20335 · 2005 · External reference
The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors
10.1097/00004728-200411000-00003 · 2004 · External reference
Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging
10.1148/radiol.2322030959 · 2004 · External reference
Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging
10.1259/bjr/68749637 · 2005 · External reference
Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients—a combined diffusion tensor imaging and 1H-MR spectroscopy study
2006 · External reference
Spatial localization in NMR spectroscopy in vivo
10.1111/j.1749-6632.1987.tb32915.x · 1987 · External reference
Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses
10.1002/jmri.1880070422 · 1997 · External reference
Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer
10.1002/(sici)1522-2594(200001)43:1<23::aid-mrm4>3.0.co;2-e · 2000 · External reference
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors
10.1006/jmre.1998.1458 · 1998 · External reference
Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors
10.1002/mrm.1183 · 2001 · External reference
An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma
10.1002/1522-2586(200102)13:2<167::aid-jmri1026>3.0.co;2-k · 2001 · External reference
A simplified method to measure the diffusion tensor from seven MR images
10.1002/mrm.1910390610 · 1998 · External reference
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
10.1007/s11060-008-9719-x · 2009 · External reference
Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging
10.1593/tlo.09178 · 2009 · External reference
Characterization of brain tumors by MRS, DWI and Ki-67 labeling index
10.1007/s11060-004-3342-2 · 2005 · External reference
Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma
10.1023/a:1006431120031 · 2000 · External reference
The role of diffusion-weighted imaging in patients with brain tumors
2001 · External reference
Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging
10.1148/radiol.2403050937 · 2006 · External reference
Correlation of MR spectroscopic and growth characteristics of grades II and III glioma
10.3171/jns.2007.106.4.660 · 2006 · External reference
